Prescient Therapeutics to present PTX-100 results at T-Cell Lymphoma Forum in California

Clinical-stage oncology company Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) has been invited to present PTX-100 Phase 1b results at the 15th Annual...

Related Keywords

United States ,California ,American ,Steven Yatomi Clarke ,Lymphoma Forum ,Prescient Therapeutics Ltd ,Drug Administration ,World Congress ,American Society Of Hematology ,Annualt Cell Lymphoma Forum ,Orphan Drug Designation ,T Cell Lymphoma Forum ,Principal Investigator ,American Society ,Annual Meeting ,